Loading...
Sign in to edit your profile (add interests, overview, photo, etc.)

    Burke, Thomas

    TitleSr Scientific Engr Assoc
    SchoolLawrence Berkeley National Lab
    DepartmentEnergy Analysis Env Impacts
    Address1 Cyclotron Road
    Berkeley CA 94720
    Phone510/486-7723
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Abernethy AP, Arunachalam A, Burke T, McKay C, Cao X, Sorg R, Carbone DP. Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting. PLoS One. 2017; 12(6):e0178420. PMID: 28644837.
        View in: PubMed
      2. Huang M, Lou Y, Pellissier J, Burke T, Liu FX, Xu R, Velcheti V. Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States. Pharmacoeconomics. 2017 Jun 15. PMID: 28620848.
        View in: PubMed
      3. Michaels D, Burke T. The dishonest HONEST Act. Science. 2017 Jun 09; 356(6342):989. PMID: 28596314.
        View in: PubMed
      4. Gwinn MR, Axelrad DA, Bahadori T, Bussard D, Cascio WE, Deener K, Dix D, Thomas RS, Kavlock RJ, Burke T. Chemical Risk Assessment: Traditional vs Public Health Perspectives. Am J Public Health. 2017 May 18; e1-e8. PMID: 28520487.
        View in: PubMed
      5. Burke T, Cascio WE, Costa DL, Deener K, Fontaine TD, Fulk FA, Jackson LE, Munns WR, Orme-Zavaleta J, Slimak MW, Zartarian VG. Rethinking Environmental Protection: Meeting the Challenges of a Changing World. Environ Health Perspect. 2017 03 01; 125(3):A43-A49. PMID: 28248180.
        View in: PubMed
      6. Samet JM, Burke T, Goldstein BD. The Trump Administration and the Environment - Heed the Science. N Engl J Med. 2017 Mar 01. PMID: 28249122.
        View in: PubMed
      7. McGinty MD, Burke T, Resnick B, Barnett DJ, Smith KC, Rutkow L. Decision Processes and Determinants of Hospital Evacuation and Shelter-in-Place During Hurricane Sandy. J Public Health Manag Pract. 2017 Jan/Feb; 23(1):29-36. PMID: 26910873.
        View in: PubMed
      8. Sell TK, McGinty EE, Pollack K, Smith KC, Burke T, Rutkow L. US State-Level Policy Responses to the Ebola Outbreak, 2014-2015. J Public Health Manag Pract. 2017 Jan/Feb; 23(1):11-19. PMID: 26672407.
        View in: PubMed
      9. Sell TK, Boddie C, McGinty EE, Pollack K, Smith KC, Burke T, Rutkow L. Media Messages and Perception of Risk for Ebola Virus Infection, United States. Emerg Infect Dis. 2017 Jan; 23(1):108-111. PMID: 27983495.
        View in: PubMed
      10. Huang M, Lou Y, Pellissier J, Burke T, Liu FX, Xu R, Velcheti V. Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States. J Med Econ. 2016 Oct 3; 1-11. PMID: 27571538.
        View in: PubMed
      11. Sell TK, Boddie C, McGinty EE, Pollack K, Smith KC, Burke T, Rutkow L. News media coverage of U.S. Ebola policies: Implications for communication during future infectious disease threats. Prev Med. 2016 Sep 21; 93:115-120. PMID: 27664539.
        View in: PubMed
      12. Burke T. Clarification on Tartari et al.: Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients. Cancer Treat Rev. 2016 Nov; 50:82. PMID: 27649326.
        View in: PubMed
      13. McGinty MD, Burke T, Barnett DJ, Smith KC, Resnick B, Rutkow L. Hospital Evacuation and Shelter-in-Place: Who Is Responsible for Decision-Making? Disaster Med Public Health Prep. 2016 Jun; 10(3):320-4. PMID: 27198183.
        View in: PubMed
      14. Birnbaum LS, Burke T, Jones JJ. Informing 21st-Century Risk Assessments with 21st-Century Science. Environ Health Perspect. 2016 Apr 1; 124(4):A60-3. PMID: 27035154.
        View in: PubMed
      15. McGinty MD, Burke T, Resnick BA, Smith KC, Barnett DJ, Rutkow L. Legal Preparedness for Hurricane Sandy: Authority to Order Hospital Evacuation or Shelter-in-Place in the Mid-Atlantic Region. Health Secur. 2016 Mar-Apr; 14(2):78-85. PMID: 27081887.
        View in: PubMed
      16. McCabe JG, Burke T. Reducing Risk by Acting on Climate. Health Secur. 2016 Mar-Apr; 14(2):43-6. PMID: 27081882.
        View in: PubMed
      17. Molassiotis A, Lee PH, Burke T, Dicato M, Gascon P, Roila F, Aapro M. Anticipatory Nausea, Risk Factors, and Its Impact on Chemotherapy-Induced Nausea and Vomiting: Results From the Pan European Emesis Registry Study. J Pain Symptom Manage. 2016 Jun; 51(6):987-93. PMID: 26891606.
        View in: PubMed
      18. Burke T, Manglani Y, Altawil Z, Dickson A, Clark R, Okelo S, Ahn R. A Safe-Anesthesia Innovation for Emergency and Life-Improving Surgeries When no Anesthetist is Available: A Descriptive Review of 193 Consecutive Surgeries. World J Surg. 2015 Sep; 39(9):2147-52. PMID: 26067637.
        View in: PubMed
      19. Suarez C, Carroll RT, Burke T, Christensen JR, Bestul AJ, Sees JA, James ML, Sirotkin V, Kovar DR. Profilin Regulates F-Actin Network Homeostasis by Favoring Formin over Arp2/3 Complex. Dev Cell. 2015 Jan 12; 32(1):43-53. PMID: 25543282.
        View in: PubMed
      20. Bestul AJ, Christensen JR, Grzegorzewska AP, Burke T, Sees JA, Carroll RT, Sirotkin V, Keenan RJ, Kovar DR. Fission yeast profilin is tailored to facilitate actin assembly by the cytokinesis formin Cdc12. Mol Biol Cell. 2015 Jan 15; 26(2):283-93. PMID: 25392301.
        View in: PubMed
      21. Kucik JE, Nembhard WN, Donohue P, Devine O, Wang Y, Minkovitz CS, Burke T. Community socioeconomic disadvantage and the survival of infants with congenital heart defects. Am J Public Health. 2014 Nov; 104(11):e150-7. PMID: 25211743.
        View in: PubMed
      22. Kim HK, Hsieh R, Chan A, Yu S, Han B, Gao Y, Baños A, Ying X, Burke T, Keefe DM. Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice. Support Care Cancer. 2015 Jan; 23(1):293-300. PMID: 25142702.
        View in: PubMed
      23. Hsieh RK, Chan A, Kim HK, Yu S, Kim JG, Lee MA, Dalén J, Jung H, Liu YP, Burke T, Keefe DM. Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries. Support Care Cancer. 2015 Jan; 23(1):263-72. PMID: 25120009.
        View in: PubMed
      24. Yu S, Burke T, Chan A, Kim HK, Hsieh RK, Hu X, Liang JT, Baños A, Spiteri C, Keefe DM. Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy-a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines. Support Care Cancer. 2015 Jan; 23(1):273-82. PMID: 25115892.
        View in: PubMed
      25. Keefe DM, Chan A, Kim HK, Hsieh RK, Yu S, Wang Y, Nicholls RJ, Burke T. Rationale and design of the Pan Australasian chemotherapy-induced emesis burden of illness study. Support Care Cancer. 2015 Jan; 23(1):253-61. PMID: 25115893.
        View in: PubMed
      26. Anderson RE, Ahn R, Nelson BD, Chavez J, de Redon E, Burke T. Defining the anesthesia gap for reproductive health procedures in resource-limited settings. Int J Gynaecol Obstet. 2014 Dec; 127(3):229-33. PMID: 25179170.
        View in: PubMed
      27. Chan A, Kim HK, Hsieh RK, Yu S, de Lima Lopes G, Su WC, Baños A, Bhatia S, Burke T, Keefe DM. Incidence and predictors of anticipatory nausea and vomiting in Asia Pacific clinical practice-a longitudinal analysis. Support Care Cancer. 2015 Jan; 23(1):283-91. PMID: 25112561.
        View in: PubMed
      28. Kucik JE, Cassell CH, Alverson CJ, Donohue P, Tanner JP, Minkovitz CS, Correia J, Burke T, Kirby RS. Role of health insurance on the survival of infants with congenital heart defects. Am J Public Health. 2014 Sep; 104(9):e62-70. PMID: 25033158.
        View in: PubMed
      29. Chan SL, Jen J, Burke T, Pellissier J. Economic analysis of aprepitant-containing regimen to prevent chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Hong Kong. Asia Pac J Clin Oncol. 2014 Mar; 10(1):80-91. PMID: 24571059.
        View in: PubMed
      30. Burke T, Christensen JR, Barone E, Suarez C, Sirotkin V, Kovar DR. Homeostatic actin cytoskeleton networks are regulated by assembly factor competition for monomers. Curr Biol. 2014 Mar 3; 24(5):579-85. PMID: 24560576.
        View in: PubMed
      31. Sheehan MC, Burke T, Navas-Acien A, Breysse PN, McGready J, Fox MA. Global methylmercury exposure from seafood consumption and risk of developmental neurotoxicity: a systematic review. Bull World Health Organ. 2014 Apr 1; 92(4):254-269F. PMID: 24700993.
        View in: PubMed
      32. Molassiotis A, Aapro M, Dicato M, Gascon P, Novoa SA, Isambert N, Burke T, Gu A, Roila F. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study. J Pain Symptom Manage. 2014 May; 47(5):839-848.e4. PMID: 24075401.
        View in: PubMed
      33. Gilmore JW, Peacock NW, Gu A, Szabo S, Rammage M, Sharpe J, Haislip ST, Perry T, Boozan TL, Meador K, Cao X, Burke T. Antiemetic Guideline Consistency and Incidence of Chemotherapy-Induced Nausea and Vomiting in US Community Oncology Practice: INSPIRE Study. J Oncol Pract. 2014 Jan 1; 10(1):68-74. PMID: 24065402.
        View in: PubMed
      34. Sheehan MC, Burke T, Breysse PN, Navas-Acien A, McGready J, Fox MA. Association of markers of chronic viral hepatitis and blood mercury levels in US reproductive-age women from NHANES 2001-2008: a cross-sectional study. Environ Health. 2012; 11:62. PMID: 22970929.
        View in: PubMed
      35. Aingaran M, Zhang R, Law SK, Peng Z, Undisz A, Meyer E, Diez-Silva M, Burke T, Spielmann T, Lim CT, Suresh S, Dao M, Marti M. Host cell deformability is linked to transmission in the human malaria parasite Plasmodium falciparum. Cell Microbiol. 2012 Jul; 14(7):983-93. PMID: 22417683.
        View in: PubMed
      36. Chari R, Burke T, White RH, Fox MA. Integrating susceptibility into environmental policy: an analysis of the national ambient air quality standard for lead. Int J Environ Res Public Health. 2012 Apr; 9(4):1077-96. PMID: 22690184.
        View in: PubMed
      37. Kufel JZ, Resnick BA, Fox M, Frattaroli S, Gielen A, Burke T. Local food protection and safety infrastructure and capacity: a Maryland case study. J Public Health Manag Pract. 2011 Nov-Dec; 17(6):534-41. PMID: 21964366.
        View in: PubMed
      38. Zablotsky Kufel JS, Resnick BA, Fox MA, McGready J, Yager JP, Burke T. The impact of local environmental health capacity on foodborne illness morbidity in Maryland. Am J Public Health. 2011 Aug; 101(8):1495-500. PMID: 21750282.
        View in: PubMed
      39. Buchholz K, Burke T, Williamson KC, Wiegand RC, Wirth DF, Marti M. A high-throughput screen targeting malaria transmission stages opens new avenues for drug development. J Infect Dis. 2011 May 15; 203(10):1445-53. PMID: 21502082.
        View in: PubMed
      40. Woodruff TJ, Burke T, Zeise L. The need for better public health decisions on chemicals released into our environment. Health Aff (Millwood). 2011 May; 30(5):957-67. PMID: 21555480.
        View in: PubMed
      41. Abt E, Rodricks JV, Levy JI, Zeise L, Burke T. Science and decisions: advancing risk assessment. Risk Anal. 2010 Jul; 30(7):1028-36. PMID: 20497395.
        View in: PubMed
      42. Fox M, Curriero F, Kulbicki K, Resnick B, Burke T. Evaluating the community health legacy of WWI chemical weapons testing. J Community Health. 2010 Feb; 35(1):93-103. PMID: 19921536.
        View in: PubMed
      43. Burke T, Wisniewski T, Ernst FR. Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting. Support Care Cancer. 2011 Jan; 19(1):131-40. PMID: 20101417.
        View in: PubMed
      44. Resnick BA, Zablotsky J, Janus ER, Maggy B, Burke T. An examination of environmental public health organizational and workforce configurations in the Northeast/Mid-Atlantic United States: how do we determine if these configurations impact performance? J Public Health Manag Pract. 2009 Nov-Dec; 15(6):509-17. PMID: 19823156.
        View in: PubMed
      45. Resnick BA, Zablotsky J, Burke T. Protecting and promoting the nation's health: the environmental public health workforce as a critical component. J Public Health Manag Pract. 2009 Nov; 15(6 Suppl):S40-5. PMID: 19829228.
        View in: PubMed
      46. Uscher-Pines L, Vernick JS, Curriero F, Lieberman R, Burke T. Disaster-related injuries in the period of recovery: the effect of prolonged displacement on risk of injury in older adults. J Trauma. 2009 Oct; 67(4):834-40. PMID: 19820593.
        View in: PubMed
      47. Rutkow L, Levin MB, Burke T. Meeting local needs while developing public health practice skills: a model community-academic partnership. J Public Health Manag Pract. 2009 Sep-Oct; 15(5):425-31. PMID: 19704311.
        View in: PubMed
      48. Chandwani S, Wentworth C, Burke T, Patterson TF. Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice. Curr Med Res Opin. 2009 Feb; 25(2):385-93. PMID: 19192983.
        View in: PubMed
      49. Malecki KC, Resnick B, Burke T. Effective environmental public health surveillance programs: a framework for identifying and evaluating data resources and indicators. J Public Health Manag Pract. 2008 Nov-Dec; 14(6):543-51. PMID: 18849774.
        View in: PubMed
      50. White RH, Cote I, Zeise L, Fox M, Dominici F, Burke T, White PD, Hattis DB, Samet JM. State-of-the-science workshop report: issues and approaches in low-dose-response extrapolation for environmental health risk assessment. Environ Health Perspect. 2009 Feb; 117(2):283-7. PMID: 19270800.
        View in: PubMed
      51. Neff RA, Curriero FC, Burke T. Just in the wrong place...?: geographic tools for occupational injury/illness surveillance. Am J Ind Med. 2008 Sep; 51(9):680-90. PMID: 18626910.
        View in: PubMed
      52. Rodes CE, Pellizzari ED, Dellarco MJ, Erickson MD, Vallero DA, Reissman DB, Lioy PJ, Lippmann M, Burke T, Goldstein BD. ISEA2007 panel: integration of better exposure characterizations into disaster preparedness for responders and the public. J Expo Sci Environ Epidemiol. 2008 Nov; 18(6):541-50. PMID: 18685563.
        View in: PubMed
      53. Phatak H, Wentworth C, Burke T. Lipid testing among patients beginning statin therapy in general practice in the United Kingdom. Value Health. 2008 Sep-Oct; 11(5):933-8. PMID: 18489501.
        View in: PubMed
      54. Kamal-Bahl SJ, Burke T, Watson DJ, Wentworth CE. Dosage, titration, and gaps in treatment with extended release niacin in clinical practice. Curr Med Res Opin. 2008 Jun; 24(6):1817-21. PMID: 18485268.
        View in: PubMed
      55. Resnick B, Zablotsky J, Nachman K, Burke T. Examining the front lines of local environmental public health practice: a Maryland case study. J Public Health Manag Pract. 2008 Jan-Feb; 14(1):42-50. PMID: 18091039.
        View in: PubMed
      56. Dreyling E, Dederick EJ, Chari R, Resnick B, Malecki KC, Burke T, Neff R. Tracking health and the environment: a pilot test of environmental public health indicators. J Environ Health. 2007 Dec; 70(5):9-16, 38, 40; quiz 41-2. PMID: 18189034.
        View in: PubMed
      57. Nachman KE, Mihalic JN, Burke T, Geyh AS. Comparison of arsenic content in pelletized poultry house waste and biosolids fertilizer. Chemosphere. 2008 Mar; 71(3):500-6. PMID: 18023841.
        View in: PubMed
      58. Burke T, Sturkenboom MC, Ohman-Strickland PA, Wentworth CE, Rhoads GG. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus. Pharmacoepidemiol Drug Saf. 2007 Sep; 16(9):979-87. PMID: 17605137.
        View in: PubMed
      59. Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Clin Ther. 2007 Aug; 29(8):1671-81. PMID: 17919548.
        View in: PubMed
      60. Resnick B, Zablotsky J, Farrow O, Glotfelty R, Heard P, Kelly S, Mitchell C, Phillips F, Burke T. Enhancing the Maryland environmental public health workforce: a collaborative approach. J Environ Health. 2007 Jul-Aug; 70(1):32-6, 63. PMID: 17802814.
        View in: PubMed
      61. Juzych NS, Resnick B, Streeter R, Herbstman J, Zablotsky J, Fox M, Burke T. Adequacy of state capacity to address noncommunicable disease clusters in the era of environmental public health tracking. Am J Public Health. 2007 Apr; 97 Suppl 1:S163-9. PMID: 17413060.
        View in: PubMed
      62. Litt JS, Wismann A, Resnick B, Dawson RS, Hano M, Burke T. Advancing health and environmental disease tracking: a 5-year follow-up study. Am J Public Health. 2007 Mar; 97(3):456-63. PMID: 17267714.
        View in: PubMed
      63. Ryan PB, Burke T, Cohen Hubal EA, Cura JJ, McKone TE. Using biomarkers to inform cumulative risk assessment. Environ Health Perspect. 2007 May; 115(5):833-40. PMID: 17520075.
        View in: PubMed
      64. Uscher-Pines L, Bookbinder SH, Miro S, Burke T. From bioterrorism exercise to real-life public health crisis: lessons for emergency hotline operations. J Public Health Manag Pract. 2007 Jan-Feb; 13(1):16-22. PMID: 17149095.
        View in: PubMed
      65. Kamal-Bahl SJ, Burke T, Watson D, Wentworth C. Discontinuation of lipid modifying drugs among commercially insured United States patients in recent clinical practice. Am J Cardiol. 2007 Feb 15; 99(4):530-4. PMID: 17293198.
        View in: PubMed
      66. Erazo Valle A, Wisniewski T, Figueroa Vadillo JI, Burke T, Martinez Corona R. Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed. Curr Med Res Opin. 2006 Dec; 22(12):2403-10. PMID: 17257454.
        View in: PubMed
      67. Burke T, Venketasubramanian RN. The epidemiology of stroke in the East Asian region: a literature-based review. Int J Stroke. 2006 Nov; 1(4):208-15. PMID: 18706018.
        View in: PubMed
      68. Keiding H, Hildebrandt P, Burke T, Carides GW. [Cost-effectiveness of treatment of high blood pressure with losartan in Denmark]. Ugeskr Laeger. 2006 Oct 16; 168(42):3623-6. PMID: 17069726.
        View in: PubMed
      69. Uscher-Pines L, Omer SB, Barnett DJ, Burke T, Balicer RD. Priority setting for pandemic influenza: an analysis of national preparedness plans. PLoS Med. 2006 Oct; 3(10):e436. PMID: 17048982.
        View in: PubMed
      70. Angerer J, Bird MG, Burke T, Doerrer NG, Needham L, Robison SH, Sheldon L, Zenick H. Strategic biomonitoring initiatives: moving the science forward. Toxicol Sci. 2006 Sep; 93(1):3-10. PMID: 16785253.
        View in: PubMed
      71. Burke T, Sturkenboom MC, Lu SE, Wentworth CE, Lin Y, Rhoads GG. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens. 2006 Jun; 24(6):1193-200. PMID: 16685222.
        View in: PubMed
      72. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke T, Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect. 2006 May; 114(5):641-8. PMID: 16675414.
        View in: PubMed
      73. McInnes G, Burke T, Carides G. Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study. J Hum Hypertens. 2006 Jan; 20(1):51-8. PMID: 16357874.
        View in: PubMed
      74. Vitezic D, Burke T, Mrsic-Pelcic J, Mavric Z, Zaputovic L, Zupan G, Simonic A. Characteristics of blood-pressure control in treated hypertensive patients in Croatia. Blood Press Suppl. 2005 Dec; 2:33-41. PMID: 16429641.
        View in: PubMed
      75. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke T, Guallar E. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol. 2005 Dec 1; 162(11):1037-49. PMID: 16269585.
        View in: PubMed
      76. Seng WK, Hwang SJ, Han DC, Teong CC, Chan J, Burke T, Carides GW, Choi YJ. Losartan reduces the costs of diabetic end-stage renal disease: an Asian perspective. Nephrology (Carlton). 2005 Oct; 10(5):520-4. PMID: 16221106.
        View in: PubMed
      77. Jönsson B, Carides GW, Burke T, Dasbach EJ, Lindholm LH, Dahlöf B. Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial. J Hypertens. 2005 Jul; 23(7):1425-31. PMID: 15942467.
        View in: PubMed
      78. Arredondo A, Burke T, Carides GW, Lemus E, Querol J. The impact of losartan on the lifetime incidence of ESRD and costs in Mexico. Rev Invest Clin. 2005 May-Jun; 57(3):399-405. PMID: 16187699.
        View in: PubMed
      79. Fox MA, Tran NL, Groopman JD, Burke T. Toxicological resources for cumulative risk: an example with hazardous air pollutants. Regul Toxicol Pharmacol. 2004 Dec; 40(3):305-11. PMID: 15546684.
        View in: PubMed
      80. Vicente-Herrero T, Burke T, Laínez MJ. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective. Curr Med Res Opin. 2004 Nov; 20(11):1805-14. PMID: 15537481.
        View in: PubMed
      81. Litt J, Tran N, Malecki KC, Neff R, Resnick B, Burke T. Identifying priority health conditions, environmental data, and infrastructure needs: a synopsis of the Pew Environmental Health tracking project. Environ Health Perspect. 2004 Oct; 112(14):1414-8. PMID: 15471735.
        View in: PubMed
      82. Dueland AN, Leira R, Burke T, Hillyer EV, Bolge S. The impact of migraine on work, family, and leisure among young women -- a multinational study. Curr Med Res Opin. 2004 Oct; 20(10):1595-604. PMID: 15462692.
        View in: PubMed
      83. Morant SV, Pettitt D, MacDonald TM, Burke T, Goldstein JL. Application of a propensity score to adjust for channelling bias with NSAIDs. Pharmacoepidemiol Drug Saf. 2004 Jun; 13(6):345-53. PMID: 15170763.
        View in: PubMed
      84. Dahlöf B, Burke T, Krobot K, Carides GW, Edelman JM, Devereux RB, Diener HC. Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. J Hum Hypertens. 2004 Jun; 18(6):367-73. PMID: 15029217.
        View in: PubMed
      85. Zhao SZ, Wentworth C, Burke T, Makuch RW. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs. Pharmacoepidemiol Drug Saf. 2004 May; 13(5):277-87. PMID: 15133778.
        View in: PubMed
      86. Payne-Sturges DC, Burke T, Breysse P, Diener-West M, Buckley TJ. Personal exposure meets risk assessment: a comparison of measured and modeled exposures and risks in an urban community. Environ Health Perspect. 2004 Apr; 112(5):589-98. PMID: 15064166.
        View in: PubMed
      87. Wolfe F, Michaud K, Burke T, Zhao SZ. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice. J Rheumatol. 2004 Feb; 31(2):355-8. PMID: 14760808.
        View in: PubMed
      88. Tran NL, Barraj L, Smith K, Javier A, Burke T. Combining food frequency and survey data to quantify long-term dietary exposure: a methyl mercury case study. Risk Anal. 2004 Feb; 24(1):19-30. PMID: 15027997.
        View in: PubMed
      89. Stern AH, Jacobson JL, Ryan L, Burke T. Do recent data from the Seychelles Islands alter the conclusions of the NRC Report on the toxicological effects of methylmercury? Environ Health. 2004 Jan 30; 3(1):2. PMID: 14754462.
        View in: PubMed
      90. Sturkenboom MC, Burke T, Tangelder MJ, Dieleman JP, Walton S, Goldstein JL. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2003 Dec; 18(11-12):1137-47. PMID: 14653834.
        View in: PubMed
      91. Goldstein JL, Zhao SZ, Burke T, Palmer R, von Allmen H, Henderson SC. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States. Am J Gastroenterol. 2003 Dec; 98(12):2627-34. PMID: 14687808.
        View in: PubMed
      92. Sturkenboom MC, Burke T, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL. Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford). 2003 Nov; 42 Suppl 3:iii23-31. PMID: 14585915.
        View in: PubMed
      93. MacDonald TM, Morant SV, Goldstein JL, Burke T, Pettitt D. Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut. 2003 Sep; 52(9):1265-70. PMID: 12912856.
        View in: PubMed
      94. Kirwan AF, Bibby AC, Mvilongo T, Riedel H, Burke T, Millis SZ, Parissenti AM. Inhibition of protein kinase C catalytic activity by additional regions within the human protein kinase Calpha-regulatory domain lying outside of the pseudosubstrate sequence. Biochem J. 2003 Jul 15; 373(Pt 2):571-81. PMID: 12710889.
        View in: PubMed
      95. Becker RV, Burke T, McCoy MA, Trotter JP. A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a Medicare Choice population. Clin Ther. 2003 Feb; 25(2):647-62. PMID: 12749519.
        View in: PubMed
      96. Litt JS, Burke T. Uncovering the historic environmental hazards of urban brownfields. J Urban Health. 2002 Dec; 79(4):464-81. PMID: 12468667.
        View in: PubMed
      97. Zhao SZ, Burke T, Whelton A, von Allmen H, Henderson SC. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors. Am J Manag Care. 2002 Oct; 8(15 Suppl):S414-27. PMID: 12416791.
        View in: PubMed
      98. Zhao SZ, Burke T, Whelton A, von Allmen H, Henderson SC. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice. Am J Manag Care. 2002 Oct; 8(15 Suppl):S392-400. PMID: 12416789.
        View in: PubMed
      99. Zhao SZ, Burke T, Whelton A, von Allmen H, Henderson SC. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors. Am J Manag Care. 2002 Oct; 8(15 Suppl):S401-13. PMID: 12416790.
        View in: PubMed
      100. Osterhaus JT, Burke T, May C, Wentworth C, Whelton A, Bristol S. Physician-reported management of edema and destabilized blood pressure in cyclooxygenase-2-specific inhibitor users with osteoarthritis and treated hypertension. Clin Ther. 2002 Jun; 24(6):969-89. PMID: 12117086.
        View in: PubMed
      101. Wolfe F, Flowers N, Burke T, Arguelles LM, Pettitt D. Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 2002 May; 29(5):1015-22. PMID: 12022317.
        View in: PubMed
      102. Goldstein JL, Eisen GM, Burke T, Peña BM, Lefkowith J, Geis GS. Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac. Aliment Pharmacol Ther. 2002 Apr; 16(4):819-27. PMID: 11929402.
        View in: PubMed
      103. Litt JS, Tran NL, Burke T. Examining urban brownfields through the public health "macroscope". Environ Health Perspect. 2002 Apr; 110 Suppl 2:183-93. PMID: 11929727.
        View in: PubMed
      104. Wolfe F, Anderson J, Burke T, Arguelles LM, Pettitt D. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy. J Rheumatol. 2002 Mar; 29(3):467-73. PMID: 11908558.
        View in: PubMed
      105. Lerner D, Reed JI, Massarotti E, Wester LM, Burke T. The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis. J Clin Epidemiol. 2002 Feb; 55(2):197-208. PMID: 11809359.
        View in: PubMed
      106. Rabeneck L, Wristers K, Goldstein JL, Eisen G, Dedhiya SD, Burke T. Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. Am J Gastroenterol. 2002 Jan; 97(1):32-9. PMID: 11808967.
        View in: PubMed
      107. Samet JM, Burke T. Turning science into junk: the tobacco industry and passive smoking. Am J Public Health. 2001 Nov; 91(11):1742-4. PMID: 11684591.
        View in: PubMed
      108. Samet JM, Burke T. The Bush administration, the environment and public health-warnings from the first 100 days. Int J Epidemiol. 2001 Aug; 30(4):658-60. PMID: 11511579.
        View in: PubMed
      109. Zabinski RA, Burke T, Johnson J, Lavoie F, Fitzsimon C, Tretiak R, Chancellor JV. An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada. Pharmacoeconomics. 2001; 19 Suppl 1:49-58. PMID: 11280105.
        View in: PubMed
      110. Burke T, Zabinski RA, Pettitt D, Maniadakis N, Maurath CJ, Goldstein JL. A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis. Pharmacoeconomics. 2001; 19 Suppl 1:33-47. PMID: 11280104.
        View in: PubMed
      111. Bensen WG, Zhao SZ, Burke T, Zabinski RA, Makuch RW, Maurath CJ, Agrawal NM, Geis GS. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo. J Rheumatol. 2000 Aug; 27(8):1876-83. PMID: 10955327.
        View in: PubMed
      112. Tran NL, Locke PA, Burke T. Chemical and radiation environmental risk management: differences, commonalities, and challenges. Risk Anal. 2000 Apr; 20(2):163-72. PMID: 10859777.
        View in: PubMed
      113. Burke T, McKee JR, Wilson HC, Donahue RM, Batenhorst AS, Pathak DS. A comparison of time-and-motion and self-reporting methods of work measurement. J Nurs Adm. 2000 Mar; 30(3):118-25. PMID: 10725940.
        View in: PubMed
      114. Burke T, Litt JS, Fox MA. Linking public health and the health of the Chesapeake Bay. Environ Res. 2000 Feb; 82(2):143-9. PMID: 10662528.
        View in: PubMed
      115. Shalauta NM, Burke T, Gordon LJ, Stern BS, Tran NL. An examination of the educational needs for environmental health and protection. J Public Health Manag Pract. 1999 Nov; 5(6):1-12. PMID: 10662058.
        View in: PubMed
      116. Burke T, McKee JR, Pathak DS, Donahue RM, Parasuraman TV, Batenhorst AS. Costs of epilepsy in an intermediate care facility for persons with mental retardation. Am J Ment Retard. 1999 Mar; 104(2):148-57. PMID: 10207578.
        View in: PubMed
      117. Burke T, Shalauta NM, Tran NL, Stern BS. The environmental Web: a national profile of the state infrastructure for environmental health and protection. J Public Health Manag Pract. 1997 Mar; 3(2):1-12. PMID: 10186707.
        View in: PubMed
      118. Patz JA, Epstein PR, Burke T, Balbus JM. Global climate change and emerging infectious diseases. JAMA. 1996 Jan 17; 275(3):217-23. PMID: 8604175.
        View in: PubMed
      119. Burke T, Sexton K. Integrating science and policy in a National Human Exposure Assessment Survey. J Expo Anal Environ Epidemiol. 1995 Jul-Sep; 5(3):283-96. PMID: 8814773.
        View in: PubMed
      120. Burke T. Understanding environmental risk: the role of the laboratory in epidemiology, evaluation, and policy setting. Clin Chem. 1992 Aug; 38(8B Pt 2):1519-22. PMID: 1643733.
        View in: PubMed
      121. Ibrahim MA, Bond GG, Burke T, Cole P, Dost FN, Enterline PE, Gough M, Greenberg RS, Halperin WE, McConnell E. Weight of the evidence on the human carcinogenicity of 2,4-D. Environ Health Perspect. 1991 Dec; 96:213-22. PMID: 1820267.
        View in: PubMed
      Thomas's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department

      A U.S. Department of Energy National Laboratory Managed by the University of California

      This site is running Profiles RNS version v2.10.0-400-g63002091.